logo
Reliance Communications stock in focus today as SBI classifies loan as ‘fraud', implicates Anil Ambani

Reliance Communications stock in focus today as SBI classifies loan as ‘fraud', implicates Anil Ambani

Business Upturn03-07-2025
By Aditya Bhagchandani Published on July 3, 2025, 08:40 IST
Shares of Reliance Communications Ltd (RCom) are expected to remain in focus today after the company disclosed that State Bank of India (SBI) has moved to classify its loan account as fraud — a step that also implicates former director Anil Ambani.
In a stock exchange filing on July 1, RCom said SBI intends to report Ambani's name to the Reserve Bank of India (RBI), sparking another round of legal battle amid the company's ongoing insolvency proceedings. The classification stems from a forensic audit conducted by BDO in 2020, which led SBI's fraud panel to flag the account. Notably, Canara Bank had declared the loan as fraud in November 2024, though that order was later overturned by the Delhi High Court.
Ambani's legal team termed SBI's move 'ex parte' and in breach of natural justice, arguing that show-cause notices issued were outdated under revised RBI rules. They maintained that Ambani had no executive role at RCom during the period in question and accused SBI of failing to share key documents required for a response.
SBI's June 13 review reportedly cited financial irregularities, including the alleged diversion of ₹12,692 crore — about 41% of total loans worth ₹31,580 crore — to connected parties. The findings claim sanctioned funds were misused, routed through subsidiaries, and masked via inter-company loans and circular transactions.
RCom, currently under an NCLT-appointed resolution professional, stated that the classification would have 'no impact' given protections under the Insolvency and Bankruptcy Code. Ambani's lawyers further argued that SBI's decision defied rulings of the Supreme Court, the Bombay High Court, and RBI guidelines, and called for withdrawal of the order and a personal hearing.
Meanwhile, RCom's shares were trading actively today as investors assessed the implications of the development.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India
Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India

Business Upturn

time5 hours ago

  • Business Upturn

Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India

By Aditya Bhagchandani Published on July 16, 2025, 17:23 IST Emcure Pharmaceuticals Ltd. and Sanofi India Ltd. (SIL) have announced an exclusive distribution and promotion agreement for Sanofi's oral anti-diabetic (OAD) products in India, effective immediately. Under this partnership, Emcure will distribute and promote SIL's widely prescribed OAD brands, including Amaryl® and Cetapin®, leveraging its deep reach and network across India. Sanofi will continue to own and manufacture these products at its plants in India and globally. The collaboration aims to expand access to trusted oral diabetes medicines to millions of patients across the country. Notably, there will be no employee transfers from Sanofi to Emcure as part of this deal. Eric Mansion, GM Pharma Southeast Asia and India at Sanofi, said: 'Over 100 million Indians live with type 2 diabetes, and more than 60% have uncontrolled blood sugar levels. With Emcure's reach, we aim to unlock the full potential of our industry-leading OADs for patients and healthcare professionals.' Satish Mehta, CEO & MD of Emcure, added: 'This partnership aligns with our mission to improve patient access to high-quality therapies and complements our existing diabetes portfolio, supporting better diabetes care nationwide.' This alliance brings together Sanofi's strong brand portfolio and Emcure's extensive distribution network, strengthening both companies' presence in the critical diabetes care segment. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Hindustan Zinc secures LoI for Rajasthan potash and halite block
Hindustan Zinc secures LoI for Rajasthan potash and halite block

Business Upturn

time5 hours ago

  • Business Upturn

Hindustan Zinc secures LoI for Rajasthan potash and halite block

Hindustan Zinc Limited (HZL) announced on July 16, 2025, that it has received a Letter of Intent (LoI) from the Ministry of Mines, Government of India, confirming it as the preferred bidder for the Jhandawali–Satipura Amalgamated Potash and Halite Block in Rajasthan. The LoI was issued under Rule 18(1) of the Mineral Auction Rules, 2015, following an e-auction conducted by the ministry. The block, located in Hanumangarh district, Rajasthan, spans an area of approximately 1,841.25 hectares and will be granted to HZL as a composite license (covering both prospecting and mining). This acquisition is aligned with HZL's strategy to diversify into other minerals and expand its resource base beyond zinc and lead. The company had earlier intimated about its bid through a letter dated May 28, 2025, and the receipt of the LoI marks the next step toward operationalizing this resource. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Godawari Power & Ispat gets environment clearance for 2 MTPA integrated steel plant in Raipur
Godawari Power & Ispat gets environment clearance for 2 MTPA integrated steel plant in Raipur

Business Upturn

time5 hours ago

  • Business Upturn

Godawari Power & Ispat gets environment clearance for 2 MTPA integrated steel plant in Raipur

By Aditya Bhagchandani Published on July 16, 2025, 18:20 IST Godawari Power & Ispat Ltd (GPIL) announced on July 16, 2025, that it has received the much-awaited environment clearance from the Ministry of Environment, Forest & Climate Change, Government of India for setting up a 2 million tonnes per annum (MTPA) integrated steel plant. The clearance was granted by the ministry's Impact Assessment Division — Industrial Projects during the 7th meeting of the Expert Appraisal Committee (EAC) held on July 9, 2025, with the minutes uploaded to the ministry's website on July 16. The proposed plant, with 2×1 MTPA modules, will be located at Village Sarora, Tahsil Tilda, District Raipur, Chhattisgarh. This approval marks a significant milestone in GPIL's expansion plans to strengthen its presence in India's steel sector while ensuring compliance with environmental and sustainability standards. The company has requested exchanges to take this information on record as per SEBI (LODR) Regulations, 2015. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store